Committed to sharing our science

Committed to sharing our science

410 results available

Safety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM

Journal of Cardiac Failure

Masri, A et al.

September 28, 2025
Association of Sociodemographic Characteristics and Healthcare Costs in Patients with Non-Obstructive Hypertrophic Cardiomyopathy

Poster, HFSA 2025

Reza, N et al.

September 28, 2025
AMBER-HFpEF: Assessment of CK-586 in a Multicenter, Blinded Evaluation of Safety and Tolerability Results in HFpEF

Poster, HFSA 2025

Januzzi, J et al.

September 27, 2025
A Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess Efficacy and Safety of Omecamtiv Mecarbil in Patients with Symptomatic Heart Failure with Severely Reduced Ejection Fraction

Poster, HFSA 2025

Felker, GM et al.

September 28, 2025
Safety and Efficacy of Aficamten in Patients with Nonobstructive Hypertrophic Cardiomyopathy: A 96-week Analysis From FOREST-HCM

Oral Presentation, HFSA 2025

Masri, A et al.

September 28, 2025